Posted 08 February, 2024

Kyverna Therapeutics, Inc. IPO completed

IPO completed detected for ticker Nasdaq:KYTX in a 424B4 filed on 08 February, 2024.

This is an initial public offering of shares of common stock of Kyverna Therapeutics, Inc.

424B4 filed on 08 February, 2024

Don't know how to trade IPO completion? Read Initial Public Offerings.

Overview of Kyverna Therapeutics, Inc.

Health Care/Life Sciences • Biotechnology

KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. The company's therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.

Market Cap
$1.24B

View Company Details

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.